Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

4.1K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.1K
Cross-bridge Cycle01:26

Cross-bridge Cycle

116.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.1K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

2.9K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
2.9K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

681
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
681
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

1.9K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Androgen Receptor Modulators: A Review of Their Therapeutic Promise and Concerns of Misuse.

Current sports medicine reports·2026
Same author

Methods for In situ Quantification of Mitochondrial Morphology in Muscle and Terminal Schwann Cells of Mice.

Journal of visualized experiments : JoVE·2026
Same author

Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

Neurology. Genetics·2026
Same author

A Borophosphate Glass Doped with Cobalt Oxide Improves Skeletal Muscle Structure and Function in Myopathic Mice.

Journal of functional biomaterials·2026
Same author

Sirolimus for the treatment of steroid-refractory hepatotoxicity following AAV gene therapy in patients with Duchenne muscular dystrophy.

Journal of neuromuscular diseases·2026
Same author

Guidelines for evaluating endothelial function in vascular tissue.

American journal of physiology. Heart and circulatory physiology·2026

Related Experiment Video

Updated: May 16, 2025

Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection
07:39

Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection

Published on: January 1, 2017

21.9K

Time Release Ion Matrix Regenerates Dystrophic Skeletal Muscle.

Jacob A Kendra1, Alexandra G Naman1, Rebekah L Blatt2

  • 1Department of Kinesiology and Sport Management, Texas A&M University, College Station, TX, 77845.

Research Square
|April 1, 2025
PubMed
Summary

A novel time-release ion matrix (TRIM) drug, CoO-TRIM, successfully restored muscle function and structure in a Duchenne Muscular Dystrophy (DMD) mouse model. This treatment promotes regeneration and vascularization, offering potential benefits for DMD patients.

Keywords:
AngiogenesisBioactive GlassCoO-TRIMMuscular DystrophyRegenerative MedicineSkeletal MuscleTime Release Ion MatrixVEGF

More Related Videos

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
06:37

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo

Published on: September 18, 2019

14.7K
Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
09:17

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

7.7K

Related Experiment Videos

Last Updated: May 16, 2025

Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection
07:39

Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection

Published on: January 1, 2017

21.9K
Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
06:37

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo

Published on: September 18, 2019

14.7K
Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
09:17

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

7.7K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Muscle Physiology

Background:

  • Duchenne Muscular Dystrophy (DMD) is a debilitating genetic disorder causing progressive muscle degeneration.
  • Current treatments for DMD focus on managing symptoms and slowing disease progression.
  • There is a critical need for therapies that can restore muscle structure and function in DMD patients.

Purpose of the Study:

  • To evaluate the efficacy of CoO-TRIM, a time-release ion matrix (TRIM) drug, in restoring muscle function and structure in an animal model of DMD.
  • To investigate the underlying mechanisms by which CoO-TRIM promotes muscle regeneration and repair.

Main Methods:

  • Utilized the D2.mdx mouse model, an established model for Duchenne Muscular Dystrophy.
  • Administered a single injection of CoO-TRIM or vehicle to the tibialis anterior (TA) muscles.
  • Assessed muscle function (active force), myofiber size, regeneration, and microvasculature at 70 days post-treatment.

Main Results:

  • CoO-TRIM treated TA muscles showed significantly greater active force and myofiber size compared to vehicle-treated controls.
  • CoO-TRIM promoted muscle regeneration and increased the expression of vascular endothelial growth factor (VEGF).
  • Enhanced muscle microvasculature was observed in CoO-TRIM treated muscles, indicating improved blood supply.

Conclusions:

  • CoO-TRIM is a first-in-class therapeutic agent that effectively restores muscle structure and function in a severe DMD model.
  • The drug stimulates growth factors and promotes angiogenesis, leading to tissue repair without observed toxicity.
  • This novel treatment strategy holds promise for both early and late-stage Duchenne Muscular Dystrophy patients.